On February 21, during a national gynecologic surgery forum in Nanjing, Prof. Chunhua Zhang’s team at the Second Affiliated Hospital of Nanjing Medical University successfully performed a robot-assisted vNOTES high sacrospinous ligament suspension using the SHURUI® surgical system. The live-streamed procedure treated a 67-year-old patient suffering from advanced uterine prolapse.
Combining the minimal invasiveness of vaginal surgery with the precision of robotic instruments, the team achieved functional restoration with minimal trauma, no visible scars, and rapid recovery. The case highlights the potential of robotic-assisted pelvic floor surgery to reduce complications and improve quality of life in elderly women—a population where uterine prolapse affects over 25% of those aged 70 and above.
This case marks a pioneering step in integrating the SHURUI® system into prolapse surgery and demonstrates its potential to enhance traditional pelvic reconstructive techniques.
.png)
.png)
Important Notes
The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other
trademarks and may not be used without permission.
